SOLY News and Press, Soliton Inc. From 05/18/20

HOUSTON, Texas , May 18, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the results from its pivotal cellulite trial have been accepted for virtual video prese...

Soliton, Inc. (SOLY) Q1 2020 Earnings Conference Call May 14, 2020, 8:30 am ET Company Participants Carol Ruth - IR, Founder & President, The Ruth Group Wally Klemp - Co-Founder and Executive Chairman Chris Capelli - Co-Founder, CEO & CSO Lori Bisson - CFO Conference...

Soliton (NASDAQ: SOLY ): Q1 GAAP EPS of -$0.19 beats by $0.02 . More news on: Soliton, Inc., Earnings news and commentary, , Read more ...

HOUSTON , May 14, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the first quarter ended March 31, 2020 . Recent Company H...

HOUSTON , May 7, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, announced today that it will report its first quarter 2020 financial results and provide a business update o...

Soliton ( SOLY ) looks like an easy short. The pre-revenue aesthetics company is trying to commercialize its technology, but a potential recession should depress mid-term demand. That issue adds to an existing cash burn problem; Soliton will need to raise capital, likely before year-end. The...

HOUSTON , April 8, 2020 /PRNewswire/ -- Soliton, Inc. (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the U.S. Patent and Trademark Office granted the Company's U.S. Application #13/798,710. The issued...

HOUSTON , April 1, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today provided an update on its business strategy and financial position in light of the current COVID-19 situatio...

HOUSTON , March 23, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today ...

HOUSTON , March 20, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today ann...